SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is currently trending following the announcement of a preliminary Phase 3 trial design for its lead candidate, CAD-1005, aimed at treating Heparin-Induced Thrombocytopenia. Investors are actively debating the company's clinical prospects and reliance on event-driven catalysts, while some community members voice concerns over potential dilution risks and the influence of automated social media activity.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is driving intense community activity and speculative buying as traders anticipate a potential breakout and further price discovery. While some market participants express caution regarding volatility and project longevity, the active community remains focused on momentum and the potential for the stock to surpass previous highs.

ProShares Trust - ProShares Ultra Semiconductors 2X Shares

ProShares Ultra Semiconductors

The ProShares Ultra Semiconductors ETF ($USD) is capturing significant investor attention as momentum in the semiconductor sector remains robust, with traders actively debating whether to scale into the fund to capitalize on the continued growth of high-performance AI hardware. Community sentiment is currently driven by the fund's leveraged exposure to industry leaders, leading to intense discussions regarding technical entry points, re-accumulation strategies during market volatility, and the fund's historical performance relative to broader technology-linked ETFs.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending due to a wave of high-value M&A activity and positive data readouts that are fueling optimism across the sector. Investors are actively discussing the potential for sector re-ratings, with many community members highlighting specific oncology and pipeline assets as undervalued opportunities for long-term growth.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending on the back of a major $2.8 billion acquisition of the Serra Verde Group, a move widely discussed by the community as a strategic step toward building an end-to-end U.S. supply chain for critical magnets. Investors are closely monitoring the resulting volatility and share dilution implications, while technical analysts debate the sustainability of the recent breakout as interest in rare earth stocks remains heightened by ongoing geopolitical supply concerns.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle Mexican Grill is facing intense investor frustration as the stock struggles with downward pressure despite recent earnings efforts and expansion plans. The community is actively debating the effectiveness of current leadership and management strategies, frequently comparing the brand's lackluster performance and service quality to more agile competitors in the fast-casual sector.

Citigroup Global Markets Holdings, Inc. provides investment banking and securities brokerage services. It offers financial advisory, research and capital raising services to corporations, governments and individuals. The company was founded in 1977 and is headquartered in New York, NY.

Citigroup Inc

Citigroup Inc. is trending as it hits fresh 52-week highs, driven by strong institutional momentum, consistent corporate buybacks, and investor optimism surrounding its multi-year strategic transformation under CEO Jane Fraser. The community is actively debating the sustainability of this parabolic rally, weighing the bank's improved operational efficiency and capital strength against concerns that the rapid price ascent may be overextended.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Elicio Therapeutics Inc.

Elicio Therapeutics Inc

Elicio Therapeutics is trending as investors focus on the company's progress with ELI-002, a cancer vaccine candidate targeting KRAS-mutant solid tumors, while discussing potential risks related to cash runway and future financing needs. Community sentiment remains split between excitement over strong preliminary clinical data and concerns regarding the necessity of capital raises or dilution to fund upcoming phase 3 trials.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently facing intense community debate, with bulls citing long-term IoT utility and accumulation strategies, while bears express significant frustration over prolonged downward price action and a perceived lack of developer communication. Market participants are closely watching the technical consolidation around key support levels while speculating on potential upcoming business news.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market volatility driven by institutional accumulation and the ongoing expansion of its healthcare AI platform, highlighted by new strategic collaborations with major pharmaceutical partners like Gilead Sciences and Merck. Community discussion is heavily focused on the stock's potential for a major technical breakout or short squeeze, with long-term investors pointing to strong revenue growth and recurring partnerships as reasons to hold despite recent price fluctuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Morningstar (NASDAQ:MORN) Upgraded to Buy at Wall Street Zen

Wall Street Zen raised Morningstar from a "hold" rating to a "buy" rating in a report on Saturday...

Which Is the Better Small-Cap ETF, Vanguard's VB or iShares' ISCB?

Key PointsThe iShares Morningstar Small-Cap ETF and Vanguard Small-Cap ETF both launched in 2004 and offer highly competitive expense ratios...

Cathie Wood buys $14.1 million of megacap tech stock

Cathie Wood, chief of Ark Investment Management, often trades during earnings season.This time, the timing worked. She picked up shares of a megacap tech company just before results, and the stock...

Peter Schiff: U.S. stocks are a 'ticking time bomb' what to buy before the crash

Transcript:Caroline WoodsMarkets are near highs, but not everyone is buying this rally. Peter Schiff has been warning about a weaker dollar, higher gold and real risk for equities. He joins us now...

Morningstar (NASDAQ:MORN) Shares Gap Down   - Here's What Happened

Morningstar (NASDAQ:MORN) Shares Gap Down - Here's What Happened...

Tesla's biggest Chinese rival just got hit by an ugly reality

Winning a war is not the same as winning a peace. You can dominate a market, break sales records, and still watch your profits get hollowed out quarter after quarter, because the market you conquered keeps demanding you charge less for the product you built.That is the situation facing BYD Co., the...

Morningstar (NASDAQ:MORN) Releases Quarterly Earnings Results, Beats Estimates By $0.53 EPS

Morningstar (NASDAQ:MORN - Get Free Report) released its quarterly earnings data on Wednesday. The business services provider reported $3.18 EPS for the quarter, beating the consensus estimate of...

Morningstar, Inc. Reports First-Quarter 2026 Financial Results

Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, reported increased revenues in the first quarter of 2026 with sustained momentum in profitability growth. In...

This iShares ETF Beats Its Mid-Cap Rival on Price -- but Not on Stability

Key PointsiShares Morningstar Small-Cap Value ETF provides a significantly lower expense ratio than iShares S&P Mid-Cap 400 Value ETF...

Startup Blockworks wants to become the crypto equivalent of Morningstar. How it plans to do it

Blockworks wants to position itself as the main data provider for the world of digital assets in a bid to attract more investors to the asset class...

Morningstar, Inc. engages in the provision of investment research. It offers Morningstar data, direct, investment management, advisor workstation, workplace solutions, pitchbook data, enterprise components, research, credit ratings and indexes. It operates through the following segments: Morningstar Data and Analytics, PitchBook, Morningstar Wealth, Morningstar Credit, Morningstar Retirement, and Corporate and All Other. The Morningstar Data and Analytics segment is involved in providing investors data, research and insights, and investment analysis to empower investment decision-making. The PitchBook segment focuses on providing investors with access to a broad collection of data and research covering the private capital markets, including venture capital, private equity, private credit and bank loans, and merger and acquisition activities. The Morningstar Wealth segment refers to model portfolios and wealth platform, practice and portfolio management software for registered investment advisers, data aggregation, enrichment capabilities, and individual investor platform. The Morningstar Credit segment includes credit ratings, research, data, and credit analytics solutions that contribute to the transparency of international and domestic credit markets. The Morningstar Retirement segment offers products designed to help individuals reach retirement goals. The company was founded by Joseph D. Mansueto on May 16, 1984, and is headquartered in Chicago, IL.

MORN
Morningstar Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MORN News

MORNMorningstar Inc